---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-029009"
form_type: "8-K"
ticker: "IRD"
cik: "0001228627"
company_name: "Opus Genetics, Inc."
filed_at: "2023-06-09T23:59:59+00:00"
generated_at: "2026-06-14T03:33:38.361361+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Ocuphire Pharma shareholders elect six directors, ratify auditor, and approve annual say-on-pay vote

## Summary
- All six director nominees elected: Cam Gallagher, Sean Ainsworth, James Manuso, Richard Rodgers, Susan Benton, Jay Pepose.
- Ratification of Ernst & Young as auditor passed with 11,172,192 votes for (99.8% of shares voted).
- Advisory vote on frequency of say-on-pay: 'every year' received 4,180,454 votes, board adopts annual frequency.
- Approximately 53.60% of outstanding shares represented at meeting (11,228,343 shares).
- Broker non-votes of 5,087,873 shares noted for director elections.

## SEC filing metadata
- accession: 0001140361-23-029009
- form_type: 8-K
- ticker: IRD
- cik: 0001228627
- company_name: Opus Genetics, Inc.
- filed_at: 2023-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1228627/000114036123029009/0001140361-23-029009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1228627/000114036123029009/brhc20054226_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-029009
- JSON: https://secwatch.observer/filing/0001140361-23-029009.json
- Plain text: https://secwatch.observer/filing/0001140361-23-029009.txt

## Key facts
- Shareholder Votes
  Opus Genetics, Inc. shareholders approved Advisory Recommendation on the Frequency of an Advisory Vote on Named Executive Officer Compensation at the 2023-06-06 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: Proposal 3 - Advisory Recommendation on the Frequency of an Advisory Vote on Named Executive Officer Compensation One Year Two Years Three Years Votes Abstain 4,180,454 293,529 1,447,777 218,710
  evidence_url: https://www.sec.gov/Archives/edgar/data/1228627/000114036123029009/0001140361-23-029009-index.htm
- Shareholder Votes
  Opus Genetics, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-06-06 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm Votes For Votes Against Votes Abstain 11,172,192 19,672 36,479
  evidence_url: https://www.sec.gov/Archives/edgar/data/1228627/000114036123029009/0001140361-23-029009-index.htm
- Shareholder Votes
  Opus Genetics, Inc. shareholders approved Election of Directors at the 2023-06-06 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: Proposal 1 - Election of Directors Nominee Votes For Votes Withheld Broker Non-Votes Cam Gallagher 4,488,270 1,652,200 5,087,873 Sean Ainsworth 5,370,425 770,045 5,087,873 James Manuso 5,318,419 822,051 5,087,873 Richard Rodgers 4,538,415 1,602,054 5,087,873 Susan Benton 5,351,488 788,982 5,087,873 Jay Pepose 5,314,552 825,918 5,087,873
  evidence_url: https://www.sec.gov/Archives/edgar/data/1228627/000114036123029009/0001140361-23-029009-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.